GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Chengdu Easton Biopharmaceuticals Co Ltd (SHSE:688513) » Definitions » 5-Year Yield-on-Cost %

Chengdu Easton Biopharmaceuticals Co (SHSE:688513) 5-Year Yield-on-Cost % : 0.97 (As of May. 26, 2024)


View and export this data going back to 2020. Start your Free Trial

What is Chengdu Easton Biopharmaceuticals Co 5-Year Yield-on-Cost %?

Chengdu Easton Biopharmaceuticals Co's yield on cost for the quarter that ended in Mar. 2024 was 0.97.


The historical rank and industry rank for Chengdu Easton Biopharmaceuticals Co's 5-Year Yield-on-Cost % or its related term are showing as below:

SHSE:688513' s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 0.54   Med: 1.03   Max: 1.53
Current: 0.97


During the past 8 years, Chengdu Easton Biopharmaceuticals Co's highest Yield on Cost was 1.53. The lowest was 0.54. And the median was 1.03.


SHSE:688513's 5-Year Yield-on-Cost % is ranked worse than
67.11% of 152 companies
in the Biotechnology industry
Industry Median: 1.8 vs SHSE:688513: 0.97

Competitive Comparison of Chengdu Easton Biopharmaceuticals Co's 5-Year Yield-on-Cost %

For the Biotechnology subindustry, Chengdu Easton Biopharmaceuticals Co's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Chengdu Easton Biopharmaceuticals Co's 5-Year Yield-on-Cost % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Chengdu Easton Biopharmaceuticals Co's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where Chengdu Easton Biopharmaceuticals Co's 5-Year Yield-on-Cost % falls into.



Chengdu Easton Biopharmaceuticals Co 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of Chengdu Easton Biopharmaceuticals Co is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5

Chengdu Easton Biopharmaceuticals Co  (SHSE:688513) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.


Chengdu Easton Biopharmaceuticals Co 5-Year Yield-on-Cost % Related Terms

Thank you for viewing the detailed overview of Chengdu Easton Biopharmaceuticals Co's 5-Year Yield-on-Cost % provided by GuruFocus.com. Please click on the following links to see related term pages.


Chengdu Easton Biopharmaceuticals Co (SHSE:688513) Business Description

Traded in Other Exchanges
N/A
Address
No. 8, Xiyuan Avenue, Chengdu High-tech Zone, Sichuan Province, Chengdu, CHN, 611731
Chengdu Easton Biopharmaceuticals Co Ltd is engaged in research and development, production and sales of chemical raw materials and chemical pharmaceutical preparations. The company's products range from Active Pharmaceutical Ingredient to finish dosage forms like capsules, tablets and injections, enabling us to take R&D discovery to industrial level, solving problems during the course of R&D, production and distribution. Its products are categorized under Active Pharmaceutical Ingredients and Fixed Dose Formulation.

Chengdu Easton Biopharmaceuticals Co (SHSE:688513) Headlines

No Headlines